Cytogenetic analysis of bone marrow cells in a 40-year-old man revealed a mosaic of two cell lines during blast crisis: one diploid with typical Ph1 chromosome (46 XY Ph1) and one with hyperdiploidy of 54 chromosomes with double Ph1 chromosome, trisomy 4, 6, 8, 18, 21 and duplication of the sex chromosomes X and Y. Immunological characterization showed common acute lymphoblastic leukemia antigen in 90% of the blasts. In spite of intensive chemotherapy the patient died in a third blast crisis 15 months after the first blast crisis, 3 months after successfully treated central nervous system relapse.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000206311 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Isolated central nervous system relapse in blast crisis of chronic myeloid leukemia: a case report.
J Yeungnam Med Sci
December 2024
Haematology Unit, Department of Pathology, Hospital Sultanah Aminah, Ministry of Health, Malaysia.
Chronic myeloid leukemia (CML) typically progresses from a chronic phase to an accelerated phase, and eventually to a blast crisis, often involving the bone marrow and peripheral blood, if left untreated. Central nervous system (CNS) involvement is an uncommon manifestation of CML, particularly as an isolated CNS relapse. Here, we present a rare case of CML in lymphoid blast crisis with an isolated CNS relapse.
View Article and Find Full Text PDFA likely case of chronic graft-versus-host disease polymyositis affecting respiratory and truncal muscles - a comprehensive diagnostic approach.
Blood Cell Ther
November 2024
Department of Haematology, Singapore General Hospital, Singapore.
Article Synopsis
- Polymyositis is a rare complication of graft-versus-host disease (GvHD) that primarily affects muscle tissues, particularly in patients after stem cell transplants.
- A 23-year-old male with chronic myeloid leukemia experienced severe muscle weakness and respiratory issues six months post-transplant, leading to the diagnosis of GvHD polymyositis through various tests including muscle biopsies and imaging.
- The patient responded positively to treatments like corticosteroids and extracorporeal photopheresis, underscoring the need for prompt diagnosis and a collaborative approach to managing this condition.
[Research on the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase].
Zhonghua Xue Ye Xue Za Zhi
October 2024
Peking University People's Hospital, Department of Pediatrics, Beijing 100044, China.
To explore the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase (CML-BP) . The clinical characteristics, treatment measures, and survival outcomes of 28 children with CML-BP were analyzed in our hospital from January 2008 to November 2022. The male to female ratio of the 28 children with CML-BP was 1.
View Article and Find Full Text PDFNavigating diagnostic dilemmas: a rare presentation of extramedullary T-lymphoblastic leukemia/lymphoma with chronic myeloid leukemia.
J Hematop
December 2024
Department of Pathology, Microbiology, and Immunology University of Nebraska Medical Center, Omaha, NE, USA.
Chronic myeloid leukemia (CML) typically presents in the chronic phase. The blast crisis phase in CML predominantly comprises the myeloid phenotype, while B-cell lymphoblastic crisis is common among the lymphoid lineages. Presentation as a T-lymphoblastic crisis is exceptionally rare.
View Article and Find Full Text PDFChronic Inflammation Deters Natural Killer Cell Fitness and Cytotoxicity in Myeloid Leukemia.
Blood Adv
November 2024
The University of Alabama at Birmingham, Birmingham, Alabama, United States.
Article Synopsis
- Natural killer (NK) cells are crucial for combating myeloid malignancies, and their function is linked to extended remission in chronic myeloid leukemia (CML), but they experience suppression during the disease.
- Research using a CML mouse model revealed that NK cells have reduced numbers, an immature state, and decreased ability to kill cancer cells, which can improve when the BCR::ABL1 protein is inhibited.
- The study found that inflammatory signals in the CML environment, particularly from TNFa, impair NK cell function, indicating that targeting inflammatory pathways could improve NK cell therapies for CML patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!